TABLE 2.
Method | Heterozygotes (N = 67) | Homozygotes (N = 42) |
---|---|---|
Sanger | 94% (63/67) | 100% (42/42) |
HipSTR | 100% (67/67) | 7% (3/42) |
Method | Heterozygotes (N = 67) | Homozygotes (N = 42) |
---|---|---|
Sanger | 94% (63/67) | 100% (42/42) |
HipSTR | 100% (67/67) | 7% (3/42) |